Medicure Inc (TSXV:MPH)
C$ 1.02 -0.07 (-6.42%) Market Cap: 10.64 Mil Enterprise Value: 5.05 Mil PE Ratio: 0 PB Ratio: 0.52 GF Score: 73/100

Q1 2019 Medicure Inc Earnings Call Transcript

May 28, 2019 / 12:30PM GMT
Release Date Price: C$5 (-16.53%)
Operator

Welcome to the first quarter 2019 conference call. My name is Paulette, and I will be your operator for today's call. (Operator Instructions) Please note that this conference is being recorded.

I will now turn the call over to Dr. Friesen. You may begin.

Albert David Friesen
Medicure Inc. - Founder, Chair, CEO & President

Thanks, Paulette, and good morning to all on the call. We appreciate your interest and participation on today's call. Joining me is the CFO, James Kinley; and Vice President Commercial, Kevin Taylor.

The number of patients using AGGRASTAT continues to increase although modestly to now just at 65%, but with pricing pressures, the net income is lower for this quarter. The revenue for the quarter ended March 31, 2019, from AGGRASTAT was $4.8 million, which was lower than Q1 2018, which was $6.1 million.

We also experienced negative earnings, substantially because of the significant investment in the market push for both ZYPITAMAG and ReDS. The adjusted EBITDA for Q1 was $1.7 million compared to -- negative $1.7

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot